LMO7 抗体 (AA 616-644)
Our Local Distributor
北京 101111
Quick Overview for LMO7 抗体 (AA 616-644) (ABIN1881503)
抗原
See all LMO7 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 616-644
-
纯化方法
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
免疫原
- This LMO7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 616-644 amino acids from the Central region of human LMO7.
-
亚型
- Ig Fraction
-
-
-
-
应用备注
- WB: 1:1000
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
缓冲液
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C,-20 °C
-
有效期
- 6 months
-
-
- LMO7 (LIM Domain 7 (LMO7))
-
别名
- LMO7
-
背景
- LMO7 contains a calponin homology (CH) domain, a PDZ domain, and a LIM domain. An F-box (FBX) domain is present in alternative splice variants. Members of the LIM protein family carry the LIM domain, a unique cysteine-rich zinc-binding domain. Members of the FBX protein family are involved in protein-protein interactions. LMO7 may be involved in protein-protein interactions. Multiple alternative splice variants have been described but their full-length sequences have not been determined.
-
分子量
- 192696
-
NCBI登录号
- NP_005349, NP_056667
-
UniProt
- Q8WWI1
抗原
-